InMed Pharmaceuticals Inc (INM) insider trading
Every open-market stock purchase and sale by InMed Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- ADAR1 Capital Management LLC (10% owner) bought $120K in the last 90 days, growing their stake 7%.
Last 12 months: insiders bought $921K (4 buys) and sold $0 (0 sales). Last close $1.36 on Sep 18, 2026.
Recent INM insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 16, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $10.8K |
| Sep 15, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $70.4K |
| Sep 14, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $36.9K |
| Jul 15, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $1.6K |
| Jun 8, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $44.9K |
| Jun 8, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $4.5K |
| Jun 5, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $78.4K |
| Jun 5, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $7.9K |
| Jun 4, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $9.6K |
| Jun 4, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $970 |
| Jun 3, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $11K |
| Jun 3, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $1.1K |
| Jun 2, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $31.5K |
| Jun 2, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $3.2K |
| Jun 1, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $23K |
| Jun 1, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $2.3K |
| May 29, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $25.4K |
| May 29, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $2.6K |
| May 21, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $52.2K |
| May 21, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $5.3K |
| May 20, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $79.6K |
| May 20, 2026 | Vivo Opportunity LLC (10% owner) | Bought | $8K |
| May 19, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $300K |
| May 19, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $110K |
| Dec 19, 2025 | John Steven Bathery (Director) | Bought (not open market) | — |
Who's trading INM
- ADAR1 Capital Management LLC, 10% owner: bought $529K (6 buys), last Sep 16, 2026
- Vivo Opportunity LLC, 10% owner: bought $392K (18 buys), last Jun 8, 2026
- Michael Woudenberg, COO: other filings, last Dec 19, 2025
- John Steven Bathery, Director: other filings, last Dec 19, 2025
- Shane Aaron Johnson, VP: other filings, last Dec 19, 2025
- Neil A Klompas, Director: other filings, last Dec 19, 2025
- Nicole Lemerond, Director: other filings, last Dec 19, 2025
- Eric A Adams, CEO: other filings, last Dec 19, 2025
- Eric C Hsu, VP: other filings, last Dec 19, 2025
- Andrew Hull, Director: other filings, last Dec 19, 2025
- Netta Jagpal, CFO: other filings, last Dec 19, 2025
Get free alerts when an insider at InMed Pharmaceuticals Inc files a new trade →